Add time:08/25/2019         Source:sciencedirect.com

IntroductionC4d, an early product in the classical/lectin complement pathway has shown potential in the evaluation of C3 glomerulopathy where its absence would support an alternative pathway abnormality. As autoimmune/genetic complement testing is not readily available to most parts of the world, glomerular C4d staining may serve as a useful additional step toward the diagnosis.

We also recommend Trading Suppliers and Manufacturers of C3:0 (cas 108321-21-7). Pls Click Website Link as below: cas 108321-21-7 suppliers